Physician profile
Abel Alfonso
NPI 1174617740
$1,576.36
in general payments reported to CMS, 2019-2025
21 companies · $53.64 in 2025
The $53.64 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.13 · 2020: $522 · 2022: $490 · 2023: $205 · 2024: $250 · 2025: $53.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $508.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $508.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $544.23 | 2020-2022 | |
| Dexcom, INC. | $313.63 | 2022-2023 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $175.04 | 2022-2024 | Wegovy |
| Lilly USA, LLC | $121.97 | 2022-2025 | Mounjaro, Zepbound, Humulin |
| Medtronic, INC. | $61.90 | 2022-2025 | Minimed 780g |
| Insulet Corporation | $55.83 | 2019-2023 | Omnipod |
| Ascendis Pharma Endocrinology INC | $49.94 | 2024-2025 | |
| Senseonics, Incorporated | $37.00 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $23.81 | 2022 | |
| Corcept Therapeutics | $21.21 | 2024 | Korlym |
| Beta Bionics, INC. | $21.10 | 2023 | Ilet Bionic Pancreas |
| Intuity Medical INC | $17.73 | 2022 | |
| Cequr Corporation | $17.18 | 2022 | |
| Abbott Laboratories | $17.07 | 2023 | Freestyle Libre 3 |
| Recordati_rare_diseases_inc. | $16.91 | 2023 | Signifor Lar, Isturisa |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $15.47 | 2022 | |
| Medtronic Minimed, INC. | $15.13 | 2019 | |
| Antares Pharma, INC. | $14.02 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $13.12 | 2022 | |
| Companion Medical, INC. | $12.40 | 2020 | |
| Radius Health, INC. | $11.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abel Alfonso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.